Osimertinib vs Pacritinib Citrate

## Osimertinib vs Pacritinib Citrate: Overview

This comparison examines the pharmacological differences between **Osimertinib** and **Pacritinib Citrate**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Osimertinib — 48 hours; Pacritinib Citrate — N/A.

## Chemical Properties

**Molecular Formula**: Osimertinib — C28H33N7O2; Pacritinib Citrate — N/A.

**Molecular Weight**: Osimertinib — 499.6050 g/mol; Pacritinib Citrate — N/A.

**Type**: Osimertinib — Small molecule; Pacritinib Citrate — Small molecule.